Is SynergyRx GLP-1 Legitimate? Platform Lists Compounded Semaglutide at $200 With Oral Tablet Options 
Medical Care Technologies (OTC PINK:MDCE) Launches Next-Generation AI Validation Program Targeting Clinical-Grade Accuracy
MESA, AZ / ACCESS Newswire / October 6, 2025 / Medical Care Technologies Inc. (OTC Pink:MDCE) announced its plan to...
Healing Realty Trust Acquires Highland Park Medical Office Building, a Fully Leased Healthcare Property in Highland Park, Illinois
Jupiter, Florida--(Newsfile Corp. - October 6, 2025) - Healing Realty Trust Inc. ("Healing Realty Trust," "HRT" or the "Company"), a...
Butterfly Network Launches First-to-Market Artificial Intelligence Gestational Age Tool in Sub-Saharan Africa to Improve Maternal Health
The new tool empowers lower skilled healthcare workers to quickly and accurately calculate gestational age, without needing image interpretation or...
Owlstone Medical Wins up to $49.1 Million Award from ARPA-H to Develop At-home Multi-Cancer-Early Detection Tests
Goal of POSEIDON is to enable accurate, low-cost, accessible cancer screening for all Americans Program to deliver first-in-class synthetic-sensor based...
Owlstone Medical Wins up to $49.1 Million Award from ARPA-H to Develop At-home Multi-Cancer-Early Detection Tests
Goal of POSEIDON is to enable accurate, low-cost, accessible cancer screening for all Americans Program to deliver first-in-class synthetic-sensor based...
Rentschler Biopharma further expands its services in Japan and South Korea and will attend BioProcess International Asia
Rentschler Biopharma SE Rentschler Biopharma is further expanding its CDMO services in Japan and South Korea. Members of Management and...
GT Biopharma to Participate in the Centurion One Capital 3rd Annual Bahamas Summit
SAN FRANCISCO, CALIFORNIA, Oct. 06, 2025 (GLOBE NEWSWIRE) -- GT Biopharma, Inc. (the “Company”) (NASDAQ: GTBP), a clinical stage immuno-oncology...
Editas Medicine Announces EDIT-401 Oral Presentation at the European Society of Gene and Cell Therapy (ESGCT) 32nd Annual Congress and Participation in Upcoming Investor Conferences
CAMBRIDGE, Mass., Oct. 06, 2025 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a pioneering gene editing company focused on...
Levels + Season Health Case Study: Dietitian Support Doubles Member Retention
Levels members who received personalized support from Season Health dietitians logged more food, made healthier purchasing decisions, and stayed active...
Exceptional Dentistry Highlights Ongoing Commitment to Patient Care in Palmdale, CA
Palmdale, CA, Oct. 06, 2025 (GLOBE NEWSWIRE) -- Exceptional Dentistry, a dental practice based in Palmdale, California, announced today that...
Arcadia Medicine Announces FDA Clearance of IND Application for a Patented Form of MDMA
SAN FRANCISCO, Oct. 06, 2025 (GLOBE NEWSWIRE) -- Arcadia Medicine (‘Arcadia’), a company developing safer empathogens to treat mental health...
LB Pharmaceuticals to Present Three Posters at 38th ECNP Congress Highlighting Clinical Activity and Safety Profile of LB-102 in Schizophrenia, Including Positive Effects on Cognition and Negative Symptoms
NEW YORK, Oct. 06, 2025 (GLOBE NEWSWIRE) -- LB Pharmaceuticals Inc (“LB Pharmaceuticals” or the “Company”) (Nasdaq: LBRX) today announced...
MMI Completes World’s First Robotic Microsurgical Intracranial Brain Surgery
First-in-human cases lay the foundation for the next frontier in robotic microsurgeryJACKSONVILLE, Fla., Oct. 06, 2025 (GLOBE NEWSWIRE) -- MMI...
Cuprina to Present Live, Answer Questions, at Skyline Signature Series™ on October 8th, 2025, at 11:00 AM ET
Individual and institutional investors, advisors, and analysts are invited to attendSINGAPORE, Oct. 06, 2025 (GLOBE NEWSWIRE) -- Cuprina Holdings (Cayman)...
Biodexa to Host Breakfast Symposium on FAP Mechanisms and Chemoprevention Trial Issues at CGA – IGC Conference on October 11, 2025
October 6, 2025 Biodexa to Host Breakfast Symposium on FAP Mechanisms and Chemoprevention Trial Issues at CGA – IGC Conference...
Daytona Beach Clinical Trial Site Now Enrolling for Heart Protection Study
DAYTONA BEACH, FLORIDA / ACCESS Newswire / October 6, 2025 / Arrow Clinical Trials, a physician-owned clinical research site based...
GATC Health’s Derisq™ AI Report Introduced at Invitation-Only Webinar Hosted by ASTR Partners
Biotech, pharma and finance leaders attend “Rethinking Risk – How AI Can Optimize Biotech Capital Allocation”IRVINE, Calif., Oct. 06, 2025...
Dyadic Applied BioSolutions Announces Milestone Achievements and Recent Company Developments
JUPITER, Fla., Oct. 06, 2025 (GLOBE NEWSWIRE) -- Dyadic International, Inc., d/b/a Dyadic Applied BioSolutions (“Dyadic”, “we”, “us”, “our”, or...
Jaguar Health Completes Meeting with FDA for Advice on Development Pathways to Advance Ongoing Crofelemer Trial for Potential Approval for Treatment of Pediatric Indication Microvillus Inclusion Disease (MVID)
Additional update: Results of ongoing investigator-initiated proof-of-concept trial in United Arab Emirates (UAE) demonstrate further reduction of total parenteral support...
NewGen Reports Total Gain from IP Acquisition of $17.9 Million for FY 2025
Valuation Report from Big Four Global Accounting Firm Sets Fair Value of Acquired IP at US$17.9 Million and Boosts NAV...